Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ATLN:VX

125.700 CHF 1.700 1.37%

As of 05:12:19 ET on 05/04/2015.

Company Profile for Actelion Ltd (ATLN)

Actelion Ltd is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for diseases with significant unmet medical needs. The Company focuses in the field of pulmonary arterial hypertension (PAH) with treatments for diseases from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.

Contact Information

Actelion Ltd

Gewerbestrasse 16
Allschwil, 4123
Switzerland
Phone: 41-61-565-65-65
Fax: 41-61-565-65-00

Key Executives for Actelion Ltd (ATLN)

Jean-Paul ClozelCEO/Co-FounderAndre C MullerExec VP/CFO
Otto SchwarzExec VP/COONicholas FrancoExec VP/Chief Bus Dev Officer
Guy BraunsteinExec VP/Head:Clinical DevMartine ClozelSenior VP/Chief Scientific Ofcr
Marian BorovskySenior VP/Secy/General CounselChristian AlbrichSenior VP/Head:Human Resources
Andrew C WeissSenior VP/Head:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil